StockData
CVRx, Inc. logo

CVRx, Inc. (CVRX) stock

CVRXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3093% below fair value
$0.50−0.03 (-5.99%)

Close on Nov 20, 2026Market cap $13.35MP/E –Yield –

CVRx gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

CVRx's gross profit for the twelve months ending Jun 30, 2026 was $53.18M, up 16.5% year over year. For fiscal 2025 it was $48.34M, up 12.5% from the year before. The highest annual figure on record is $48.34M in fiscal 2025.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025$48.34M+12.5%
FY2024Dec 31, 2024$42.96M+30.0%
FY2023Dec 31, 2023$33.04M+89.1%
FY2022Dec 31, 2022$17.47M+85.9%
FY2021Dec 31, 2021$9.40M+103.7%
FY2020Dec 31, 2020$4.61M–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$13.72M+19.9%
Q1 FY2026Mar 31, 2026$12.88M+24.9%
Q4 FY2025Dec 31, 2025$13.83M+8.3%
Q3 FY2025Sep 30, 2025$12.75M+14.6%
Q2 FY2025Jun 30, 2025$11.45M+15.6%
Q1 FY2025Mar 31, 2025$10.31M+12.6%
Q4 FY2024Dec 31, 2024$12.77M+33.2%
Q3 FY2024Sep 30, 2024$11.13M+26.1%
Q2 FY2024Jun 30, 2024$9.91M+24.1%
Q1 FY2024Mar 31, 2024$9.16M+37.6%
Q4 FY2023Dec 31, 2023$9.59M+69.1%
Q3 FY2023Sep 30, 2023$8.82M+82.0%
Q2 FY2023Jun 30, 2023$7.98M+108.4%
Q1 FY2023Mar 31, 2023$6.65M+112.7%
Q4 FY2022Dec 31, 2022$5.67M+111.9%
Q3 FY2022Sep 30, 2022$4.85M+92.4%
Q2 FY2022Jun 30, 2022$3.83M+73.3%
Q1 FY2022Mar 31, 2022$3.13M+56.9%
Q4 FY2021Dec 31, 2021$2.67M+63.3%
Q3 FY2021Sep 30, 2021$2.52M+220.9%
Q2 FY2021Jun 30, 2021$2.21M+144.2%
Q1 FY2021Mar 31, 2021$1.99M–
Q4 FY2020Dec 31, 2020$1.64M–
Q3 FY2020Sep 30, 2020$785.00K–
Q2 FY2020Jun 30, 2020$905.00K–

More CVRx figures

See a number that looks wrong?